Abstract
We have studied the effect of chronic treatment with imipramine, citalopram and electroconvulsive shock (ECS) on serum and brain zinc levels in rats. Chronic treatment with citalopram (but not with imipramine or ECS) significantly (approx 20%) increased the serum zinc level. Chronic treatment with both drugs slightly (by approx 10%) increase the zinc level in the hippocampus and slightly decreased it in the cortex, cerebellum and basal forebrain. Calculation of the ratio hippocampus/brain region within each group demonstrated a significantly (approx 20%) higher value after treatment with either imipramine or citalopram. Moreover, chronic ECS induced a significant increase (by 30%) in the zinc level in the hippocampus and also a slight increase (by 11–15%) in the other brain regions. Thus, these different antidepressant therapies induced an elevation of the hippocampal zinc concentration, which indicates a significant role of zinc in the mechanism of antidepressant therapy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
C. J. Frederickson, Neurobiology of zinc and zinc-containing neurons,Int. Rev. Neurobiol. 31, 145–238 (1989).
N. L Harrison, and S. J. Gibbons, Zn2+: an endogenous modulator of ligand and voltage-gated ion channels,Neuropharmacology 33, 935–952 (1994).
G. L. Westbrook and M.L. Mayer, Micromolar concentrations of Zn2+ antagonize NMDA and GABA responses of hippocampal neurons,Nature 328, 640–643 (1987).
X. Xie and T. Smart, A physiological role for endogenous zinc in rat hippocampal synaptic neurotransmission,Nature 349, 521–524 (1991).
F. M. Zhou and J. J. Hablitz, Zinc enhances GABAergic transmission in rat neocortical neurons,J. Neurophysiol. 70, 1264–1269 (1993).
M. Maes, P. C. D’Haese, S. Scharpe, P. D. D’Hondt, P. Cosyns, and M. E. De Broe, Hypozincemia in depression,J. Affect. Disorders 31, 135–140 (1994).
M. Maes, E. Vandoolaeghe, H. Neels, P. Demedts, A. Wauters, H. Y. Meltzer, C. et al., Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness,Biol. Psychiat. 42, 349–358 (1997).
I. J. McLoughlin and J. S. Hodge, Zinc in depressive disorder,Acta Psychiatr. Scand. 82, 451–453 (1990).
T. Maj, E. Przegaliński, and E. Mogilnicka, Hypotheses concerning the mechanism of action of antidepressant drugs,Rev. Physiol. Biochem. Pharmacol. 100, 1–74 (1984).
N.-Y. Huang, R. T. Layer, and P. Skolnick, Is adaptation of NMDA receptors an obligatory step in antidepressant action? InAntidepressants. New pharmacological strategies, P. Skolnick ed., Humana, Totowa, NJ, pp. 125–143 (1997).
P. Skolnick, R. T. Layer, P. Popik, G. Nowak, I. A. Paul, and R. Trullas, R. Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression,Pharmacopsychiatry 29, 23–26 (1996).
I. J. Reynolds and R. J. Miller, Tricyclic antidepressants block N-methyl-D-aspartate receptors: similarities to the action of zinc,Br. J. Pharmacol. 95, 95–102 (1988).
L.E. Hollister, J. G. Csernansky,Clinical Pharmacology of Psychotherapeutic Drugs, 3rd ed., Churchill Livingston, New York (1990).
S. A. Montgomery, Efficacy in long-term treatment of depression,J. Clin. Psychiatry 57 (suppl. 2), 24–30 (1996).
G. Nowak, Y. Li, and I. A. Paul, Adaptation of cortical but not hippocampal glutamate-NMDA receptors after chronic citalopram treatment,Eur. J. Pharmacol. 295, 75–85 (1996).
G. Nowak, R. Trullas, R. T. Layer, P. Skolnick, and I. A. Paul, Adaptive changes in the N-methyl-D-aspartate receptor complex after chronic treatment with imipramine and 1-aminocyclopropanecarboxylic acid,J. Pharmacol. Exp. Ther. 265, 1380–1386 (1993).
I. A. Paul, R. T. Layer, P. Skolnick, and G. Nowak, Adaptation of the NMDA receptor in rat cortex following chronic electroconvulsive shock or imipramine,Eur. J. Pharmacol.-Molec. Pharm. 247, 305–311 (1993).
I. A. Paul, G. Nowak, R. T. Layer, P. Popik, and P. Skolnick, Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments,J. Pharmacol. Exp. Ther. 269, 95–102 (1994).
C. Steward, K. Jeffrey, and I. Reid, LTP-like synaptic efficacy changes following electroconvulsive stimulation,NeuroReport 5, 1041–1044 (1994).
C. Steward and I. Reid, Electroconvulsive stimulation and synaptic plasticity in the rat,Brain Res. 620, 139–141 (1993).
P. S. Terse and H. L. Komiskey, Modulation of a competitive N-methyl-D-aspartate receptor antagonist binding by zinc oxide,Brain Res. 744, 347–350 (1997).
J. W. Olney, Role of excitotoxins in developmental neuropathology,APMIS 101 (suppl. 40), 103–112 (1993).
H. Monyer, N. Burnashev, D. J. Laurie, B. Sakmann, and P. H. Seeburg, Developmental and regional expression in the rat brain and functional properties of four NMDA receptors,Neuron 12, 529–540 (1994).
T. Yoshikawa, M. Ikeda, H. Tomita, A. Kida, T. Kubo, K. Ishikawa, et al., Drug influence on intestinal zinc absorption.Chem. Abstr. 126, 90 (1997).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nowak, G., Schlegel-Zawadzka, M. Alterations in serum and brain trace element levels after antidepressant treatment. Biol Trace Elem Res 67, 85–92 (1999). https://doi.org/10.1007/BF02784278
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02784278